CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-23 | Sigal Charles Elliott Director | Grant or award | +6,405 | 9,779 | ||
| 2022-05-23 | Sigal Charles Elliott Director | Grant or award · Stock Option (Right to Buy) | +12,810 | 12,810 | ||
| 2022-05-23 | SATO VICKI L Director | Grant or award | +6,405 | 1,509,868 | ||
| 2022-05-23 | SATO VICKI L Director | Grant or award · Stock Option (Right to Buy) | +12,810 | 12,810 | ||
| 2022-05-23 | PEREZ ROBERT J Director | Grant or award | +6,405 | 9,779 | ||
| 2022-05-23 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +12,810 | 12,810 | ||
| 2022-05-23 | MORE ROBERT J Director | Grant or award | +6,405 | 42,435 | ||
| 2022-05-23 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +12,810 | 12,810 | ||
| 2022-05-23 | Hatfield Jeffrey S. Director | Grant or award | +6,405 | 9,779 | ||
| 2022-05-23 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +12,810 | 12,810 | ||
| 2022-05-23 | Ramasastry Saira Director | Grant or award | +6,405 | 9,779 | ||
| 2022-05-23 | Ramasastry Saira Director | Grant or award · Stock Option (Right to Buy) | +12,810 | 12,810 | ||
| 2022-05-09 | SATO VICKI L Director | Sale | −14,541 | $20.62 | $300K | 1,503,463 |
| 2022-04-28 | SATO VICKI L Director | Sale | −14,093 | $20.74 | $292K | 1,521,826 |
| 2022-04-28 | SATO VICKI L Director | Sale | −3,822 | $21.49 | $82K | 1,518,004 |
| 2022-04-15 | Pang Phillip Chief Medical Officer | Gift | −7,777 | 148,991 | ||
| 2022-03-30 | HANLY ANN M. Chief Technology Officer | Sale | −2,627 | $26.24 | $69K | 81,473 |
| 2022-03-10 | SCANGOS GEORGE A President and CEO | Grant or award | +111,000 | 223,989 | ||
| 2022-03-10 | SCANGOS GEORGE A President and CEO | Grant or award · Stock Option (Right to Buy) | +222,000 | 222,000 | ||
| 2022-03-10 | Virgin Herbert EVP, Research & CSO | Option exercise | +9,000 | $1.53 | $14K | 184,407 |
Page 28 of 54 · 1,063 trades